(Q38236013)

31 August 2017

Treating hypertension in type 2 diabetes (English)

1 reference

31 August 2017

1 reference

Yoni Grossman

1

1 reference

31 August 2017

Gadi Shlomai

series ordinal

2

1 reference

31 August 2017

Ehud Grossman

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 August 2014

1 reference

Expert Opinion on Pharmacotherapy

31 August 2017

1 reference

31 August 2017

15

1 reference

31 August 2017

15

1 reference

31 August 2017

2131-2140

1 reference

Blood pressure and diabetes: vicious twins

31 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Adiponectin and lipoprotein particle size: response to Weiss et Al.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Management of hypertension: summary of NICE guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Are calcium antagonists beneficial in diabetic patients with hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of different calcium antagonists on proteinuria associated with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effect of calcium channel blockers on incidence of diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Influence of diabetes and type of hypertension on response to antihypertensive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Temporal trends in management of hypertension among Israeli adults, 2002-2010: lesson from the Acute Coronary Syndromes Israeli Survey (ACSIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Management of blood pressure in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Should we change the target blood pressure in diabetic patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Hypertension Optimal Treatment (HOT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

Efficacy of Add-On Aldosterone Receptor Blocker in Uncontrolled Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2014.947267

10.1517/14656566.2014.947267

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference